Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.32%
1,100.57
-3.53
-0.32%
—1,104.101,103.921,108.751,097.16——
SIXC
Communications
SIXC
Communications
SIXC
+0.16%
605.15
+0.99
+0.16%
—604.16604.16610.19604.12——
SIXE
Energy
SIXE
Energy
SIXE
-0.22%
1,195.19
-2.62
-0.22%
—1,197.811,200.581,213.071,192.02——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.03%
1,739.91
-0.50
-0.03%
—1,740.411,739.551,750.271,730.60——
SIXM
Financials
SIXM
Financials
SIXM
+0.65%
638.56
+4.12
+0.65%
—634.44633.13639.87633.01——
SIXR
Staples
SIXR
Staples
SIXR
-1.11%
831.57
-9.33
-1.11%
—840.90839.53841.73831.10——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.82%
213.36
-1.77
-0.82%
—215.13215.13215.85213.24——
SIXT
Technology
SIXT
Technology
SIXT
+0.17%
3,234.18
+5.47
+0.17%
—3,228.713,225.623,235.433,198.95——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.02%
935.65
-0.22
-0.02%
—935.87938.37942.00935.65——
SIXV
Health care
SIXV
Health care
SIXV
-0.54%
1,449.26
-7.86
-0.54%
—1,457.121,452.741,466.881,449.18——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,382.45
-17.39
-0.72%
—2,399.842,389.712,394.612,371.22——
TNXP:NASDAQ
Tonix Pharmaceuticals Holding Corp
$12.84
+1.82%
(+0.23) 1D
$12.53
-2.41% (-0.31)
Pre-market
Closed: Apr 27, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TNXP...
Open
$12.75
High
$13.05
Low
$12.62
Mkt. cap
182.40M
Avg. vol.
468.22K
Volume
3.08K
52-wk high
$69.97
52-wk low
$11.60
EPS
-$14.57
Beta
1.75
Shares outstanding
14.20M
No. of employees
142
News stories
From sources across the web
Stock Traders Daily
Stock Traders Daily
·
20 hours ago
(TNXP) Risk Channels and Responsive Allocation
Profile
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project. Wikipedia
About Tonix Pharmaceuticals Holding Corp
CEOSeth Lederman
Employees142
Founded2007
HeadquartersChatham, New Jersey, United States
SectorBiotechnology
Websitetonixpharma.com
Last report
Mar 12, 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
-3.98/ (-2.94 est.)USD
-35.44%miss
Revenue / Estimate
5.39M/ (2.97M est.)USD
+81.69%beat
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
2.43M
2.00M
3.29M
5.39M
Cost of goods sold
943.00K
3.27M
1.37M
1.06M
Cost of revenue
943.00K
3.27M
1.37M
1.06M
Research and development expenses
7.44M
10.82M
9.29M
16.94M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.10M
16.20M
25.70M
35.68M
Operating expense
17.54M
27.02M
34.99M
52.62M
Total operating expenses
18.48M
30.29M
36.36M
53.68M
Operating income
-16.05M
-28.30M
-33.07M
-48.29M
Other non operating income
1.32M
-919.00K
-174.00K
32.00K
EBT including unusual items
-16.83M
-28.27M
-32.01M
-46.91M
EBT excluding unusual items
-14.74M
-28.27M
-32.01M
-46.91M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-16.83M
-28.27M
-32.01M
-46.91M
Net profit margin
-692.84%
-1,415.02%
-972.95%
-870.32%
Earnings per share
-2.64
-4.00
-3.70
-3.98
Interest and investment income
-
943.00K
1.23M
1.34M
Interest expense
-
-
-
-
Net interest expenses
-
943.00K
1.23M
1.34M
Depreciation and amortization charges
-
-
-
-
EBITDA
-15.56M
-27.81M
-32.61M
-47.80M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer